MDMB-CHMINACA
CAS :
Ref. 3D-CM175116
Informations sur le produit
Nom:MDMB-CHMINACA
Produit contrôlé
Marque:Biosynth
Description :MDMB-CHMINACA is a synthetic cannabinoid that has been shown to have potent antagonistic effects at the CB2 receptor, which may be due to its ability to inhibit lipid metabolism in human liver cells. MDMB-CHMINACA has also been shown to have high binding affinities for both the CB1 and CB2 receptors and is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. The compound's structural analysis was validated using LC-MS/MS methods. Urine samples from individuals who had consumed MDMB-CHMINACA were analyzed using this method and showed that the compound could not be detected in urine samples with concentrations below 2 μg/mL.
Avis:Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Propriétés chimiques
Degré de pureté :Min. 95%